West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 628,500 | 509,700 | 404,200 | 484,600 | 490,900 |
| Receivables | 625,000 | 582,400 | 543,600 | 552,500 | 524,300 |
| Inventories | 438,000 | 421,100 | 388,700 | 377,000 | 401,200 |
| Other current assets | 131,800 | 167,700 | 121,000 | 124,000 | 134,200 |
| TOTAL | $1,823,300 | $1,680,900 | $1,457,500 | $1,538,100 | $1,550,600 |
| Non-Current Assets | |||||
| PPE Net | 1,740,600 | 1,722,000 | 1,631,700 | 1,581,600 | 1,571,000 |
| Investments And Advances | 220,900 | 224,700 | 211,900 | 202,100 | 217,500 |
| Intangibles | 119,500 | 120,600 | 117,500 | 116,800 | 121,100 |
| Other Non-Current Assets | 201,500 | 204,600 | 199,600 | 204,800 | 214,900 |
| TOTAL | $2,282,500 | $2,271,900 | $2,160,700 | $2,105,300 | $2,124,500 |
| Total Assets | $4,105,800 | $3,952,800 | $3,618,200 | $3,643,400 | $3,675,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 255,800 | 239,000 | 228,400 | 239,300 | 224,300 |
| Accrued Expenses | 111,800 | 93,400 | 67,800 | 73,500 | 79,600 |
| Other current liabilities | 213,100 | 222,800 | 186,400 | 188,200 | 159,300 |
| TOTAL | $635,400 | $604,600 | $526,700 | $550,400 | $516,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 202,700 | 202,600 | 202,600 | 202,600 | 202,600 |
| Other Non-Current Liabilities | 179,900 | 181,000 | 173,100 | 172,200 | 179,300 |
| TOTAL | $418,900 | $419,100 | $408,400 | $410,700 | $406,500 |
| Total Liabilities | $1,054,300 | $1,023,700 | $935,100 | $961,100 | $923,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,943 | 71,907 | 71,845 | 72,304 | 72,422 |
| Common Shares | 18,800 | 18,800 | 18,800 | 18,800 | 18,800 |
| Retained earnings | 4,262,400 | 4,139,200 | 4,031,200 | 3,956,600 | 3,856,900 |
| Other shareholders' equity | -102,700 | -88,900 | -205,700 | -258,200 | -135,900 |
| TOTAL | $3,051,500 | $2,929,100 | $2,683,100 | $2,682,300 | $2,752,100 |
| Total Liabilities And Equity | $4,105,800 | $3,952,800 | $3,618,200 | $3,643,400 | $3,675,100 |